Yunkang Group Limited (HK:2325) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Yunkang Group Limited has successfully passed a resolution at its extraordinary general meeting, approving a new procurement agreement with Daan Gene Co., Ltd. for the purchase of reagents, consumables, and equipment from 2025 to 2027. With 100% of eligible votes cast in favor, the agreement sets annual caps of up to RMB64.193 million by 2027, marking a significant step for the company in securing essential supplies for future operations.
For further insights into HK:2325 stock, check out TipRanks’ Stock Analysis page.